title: Intraductal Papillary Mucinous Neoplasm of Pancreas.
abstract: Intraductal papillary mucinous neoplasms (IPMNs) of the pancreas are neoplasms that are characterized by ductal dilation, intraductal papillary growth, and thick mucus secretion. This relatively recently defined pathology is evolving in terms of its etiopathogenesis, clinical features, diagnosis, management, and treatment guidelines. A PubMed database search was performed. All the relevant abstracts in English language were reviewed and the articles in which cases of IPMN could be identified were further scrutinized. Information of IPMN was derived, and duplication of information in several articles and those with areas of persisting uncertainties were excluded. The recent consensus guidelines were examined. The reported incidence of malignancy varies from 57% to 92% in the main duct-IPMN (MD-IPMN) and from 6% to 46% in the branch duct-IPMN (BD-IPMN). The features of high-risk malignant lesions that raise concern include obstructive jaundice in a patient with a cystic lesion in the pancreatic head, the findings on radiological imaging of a mass lesion of >30 mm, enhanced solid component, and the main pancreatic duct (MPD) of size ≥10 mm; while duct size 5-9 mm and cyst size <3 mm are considered as "worrisome features." Magnetic resonance imaging (MRI) and endoscopic ultrasound (EUS) are primary investigations in diagnosing and following up on these patients. The role of pancreatoscopy and the analysis of aspirated cystic fluid for cytology and DNA analysis is still to be established. In general, resection is recommended for most MD-IPMN, mixed variant, and symptomatic BD-IPMN. The 5-year survival of patients after surgical resection for noninvasive IPMN is reported to be at 77-100%, while for those with invasive carcinoma, it is significantly lower at 27-60%. The follow-up of these patients could vary from 6 months to 1 year and would depend on the risk stratification for invasive malignancy and the pathology of the resected specimen. The understanding of IPMN has evolved over the years. The recent guidelines have played a role in this regard.
authors.affiliation: Department of Surgery, Sultan Qaboos University Hospital, Muscat, Oman.
authors.forename: Norman Oneil
authors.initials: NO
authors.lastname: Machado
authors.affiliation: Department of Surgery, Sultan Qaboos University Hospital, Muscat, Oman.
authors.forename: Hani
authors.initials: H
authors.lastname: Al Qadhi
authors.affiliation: Department of Surgery, Sultan Qaboos University Hospital, Muscat, Oman.
authors.forename: Khalifa
authors.initials: K
authors.lastname: Al Wahibi
keywords: Carcinoma of pancreas; Cystic tumors of pancreas; Intraductal papillary mucinous neoplasm (IPMN); Magnetic resonance cholangiopancreatography (MRCP)